Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for GAD Switching from Alprazolam
NCT00368745Phase 3Completed
- Sponsor
- Viatris
- Start
- Sep 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of pregabalin in generalized anxiety disorder (GAD), sponsored by Viatris. Started Sep 2006; status: completed.
02
Drugs
pregabalin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00368745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368745.